Over 80% of transport processes due to ion channels and transporters are localized inside the cells where they play a crucial role in maintaining ion homeostasis and signaling, thus regulating several physiological processes such as apoptosis and lysosomal degradation.
Organellar ion channels and transporters are emerging as key disease modulators and promising targets for the treatment of cancer, pain, neurological disorders, and aging. There is a need to overcome the challenges associated with studying these targets at organellar level and increase the degree of resolution when characterizing new drug candidates.
Your channel, our solution
As a unique addition to our electrophysiology platform, we have implemented and developed cutting-edge techniques to allow the functional and pharmacological study of electrogenic transporters and ion channels directly at organelle level.
Driven by the desire to translate our clients’ needs into innovative solutions, our expert scientific team overcame technical challenges to establish NucleoPatch, LysoPatch and MitoPatch assays aiming to study electrogenic proteins in their native environment (nuclei, lysosomes, and mitochondria, respectively), and pioneering new tools for drug discovery industry.
Our clients can take advantage of our exclusive expertise in recording ion channel activity by manual patch clamp on intact organelles to perform a comprehensive biophysical and pharmacological characterization to identify hit compounds.
Discover below our capabilities in a nutshell
We don’t stop innovating!
Increased throughput by ad hoc adaptation of QPatch 16X protocol to enable work on isolated lysosomes.